Nairobi — Over six months after UNAids and six drug companies agreed in principle to reduce the prices of HIV drugs in developing countries, especially in Africa, people on the continent are still dying of the disease because the proposal has largely remained unimplemented.
Only one country on the continent, Senegal, has so far made any headway in implementing the price reductions, according to a statement issued last week by 1999 Nobel Peace Price winners, Medicins Sans Frontieres (MSF), on behalf of the Kenya Coalition on Access to Essential Medicines. 900 patients are however expected to benefit from the Senegal initiative.
...